Medical device reports from between Oct. 15, 2018, and March 31, 2019, included three reports of death, 45 reports of patient infection and 159 reports of device contamination tied to inadequate reprocessing of duodenoscopes used in procedures involving the pancreas and bile duct, according to an article on the MedTech Dive website.
The Food and Drug Administration (FDA) also released interim results from post-market studies by device makers showing contamination rates in the scopes significantly higher than preliminary findings released in December.
A total of 5.4% of all samples tested positive for “high concern” bacteria, versus 3% reported previously.
Manufacturers Olympus, Fujifilm and Pentax have not complied with agreed-upon timetables for completing the post-market studies, FDA said.
A 'Superbug' Is on the Rise in Hospitals
The Next Generation of Security Tech in Healthcare Facilities
Encompass Health Rehabilitation Hospital of St. Petersburg Opens
Why More Facilities are Adding Gender Neutral Restrooms
Massachusetts Hospital Cyberattack Reflects Growing Vulnerability in Healthcare Systems